Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-195909
Filing Date
2026-04-30
Accepted
2026-04-30 13:03:10
Documents
13
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A dcoy-20251231.htm   iXBRL 10-K/A 658703
2 EX-31.3 dcoy-ex31_3.htm EX-31.3 8346
3 EX-31.4 dcoy-ex31_4.htm EX-31.4 8517
  Complete submission text file 0001193125-26-195909.txt   1011433

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dcoy-20251231.xsd EX-101.SCH 45338
17 EXTRACTED XBRL INSTANCE DOCUMENT dcoy-20251231_htm.xml XML 14913
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Decoy Therapeutics Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36812 | Film No.: 26922548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)